Find in Library

P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?

oleh: M. Calamac, N. Stanic, O. Djurmez, M. Dimitrijevic, J. Vukosavljevic, K. Serovic, J. Oblakovic-Babic, I. Minic, I. Bozovic-Spasojevic